NuCana plc has filed a prospectus as part of its registration statements on Form F-3 and Form S-8, which have been amended and are related to the company's at-the-market $(ATM.UK)$ offerings. The prospectus and registration statements, originally filed under File Numbers 333-281576, 333-223476, and 333-248135, have been updated to reflect recent developments including the termination of the Jefferies Sales Agreement. This agreement, which allowed NuCana to sell up to $100 million through Jefferies LLC, was terminated effective June 27, 2025, without incurring any termination penalties. The updates are part of NuCana's ongoing efforts to manage its financial strategies effectively.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.